TG
EW icon

TCW Group’s Edwards Lifesciences EW Stock Holding History

TCW Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.23M Sell
24,644
-1,452
-6% -$122K 0.02% 274
2026
Q1 		$2.09M Sell
26,096
-446
-2% -$36.8K 0.02% 273
2025
Q4 		$2.26M Buy
26,542
+8,195
+45% +$673K 0.02% 267
2025
Q3 		$1.43M Sell
18,347
-9,278
-34% -$725K 0.01% 205
2025
Q2 		$2.16M Buy
27,625
+185
+0.7% +$13.8K 0.02% 252
2025
Q1 		$1.99M Buy
27,440
+4,575
+20% +$327K 0.02% 253
2024
Q4 		$1.69M Buy
+22,865
New +$1.6M 0.01% 270
2021
Q2 		– Sell
-13,962
Closed -$1.17M – 343
2021
Q1 		$1.17M Hold
13,962
– – 0.01% 282
2020
Q4 		$1.27M Sell
13,962
-2,495
-15% -$207K 0.01% 275
2020
Q3 		$1.31M Buy
16,457
+41
+0.2% +$3.2K 0.01% 253
2020
Q2 		$1.14M Buy
+16,416
New +$1.17M 0.01% 237
2017
Q1 		– Sell
-47,250
Closed -$1.48M – 462
2016
Q4 		$1.48M Hold
47,250
– – 0.01% 418
2016
Q3 		$1.9M Sell
47,250
-3,900
-8% -$147K 0.01% 341
2016
Q2 		$1.7M Buy
51,150
+1,200
+2% +$41.1K 0.01% 364
2016
Q1 		$1.47M Buy
49,950
+150
+0.3% +$4.14K 0.01% 406
2015
Q4 		$1.31M Buy
+49,800
New +$1.29M 0.01% 442
2015
Q2 		– Sell
-188,100
Closed -$4.47M – 678
2015
Q1 		$4.47M Buy
188,100
+8,100
+5% +$182K 0.02% 406
2014
Q4 		$3.82M Sell
180,000
-131,700
-42% -$2.65M 0.02% 469
2014
Q3 		$5.31M Sell
311,700
-5,400
-2% -$85.2K 0.02% 463
2014
Q2 		$4.54M Sell
317,100
-2,700
-0.8% -$36.6K 0.02% 522
2014
Q1 		$3.95M Sell
319,800
-5,100
-2% -$58.8K 0.02% 548
2013
Q4 		$3.56M Sell
324,900
-7,500
-2% -$84.5K 0.02% 578
2013
Q3 		$3.86M Sell
332,400
-660
-0.2% -$7.72K 0.02% 556
2013
Q2 		$3.73M Buy
+333,060
New +$3.94M 0.02% 525

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

TCW Group's EW Position: Q2 2026 in Review

TCW Group reduced its Edwards Lifesciences (EW) stake by 5.6% in Q2 2026, selling an estimated $122K and leaving 24,644 shares worth $2.23M. The position accounts for 0.02% of the portfolio, ranked #274.

TCW Group first reported a position in EW in Q2 2013 and has held it in 24 quarters since. The position peaked at $5.31M in Q3 2014. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • TCW Group held 24,644 shares of Edwards Lifesciences worth $2.23M as of Q2 2026.
  • TCW Group sold 1,452 Edwards Lifesciences shares in Q2 2026, an estimated $122K.
  • Edwards Lifesciences made up 0.02% of TCW Group's portfolio in Q2 2026, its #274 holding.
  • TCW Group first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 24 quarters since.
  • TCW Group's Edwards Lifesciences position peaked at $5.31M in Q3 2014.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on TCW Group's 13F filing for Q2 2026, filed 3 Aug 2026.